Theialife’s race to bring a childhood myopia treatment to market
Our guest today is Thomas Ruggia, CEO of Theialife, a late-stage biotech developing an oral therapy for pediatric myopia derived from a natural caffeine metabolite. The post Theialife’s race to bring a childhood myopia treatment to market appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission…
We haven't written up this one. Labiotech has the full story — the link below goes straight to it.
